Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

211 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Incidence, risk factors and outcomes of submacular haemorrhage with loss of vision in neovascular age-related macular degeneration in daily clinical practice: data from the FRB! registry.
Gabrielle PH, Maitrias S, Nguyen V, Arnold JJ, Squirrell D, Arnould L, Sanchez-Monroy J, Viola F, O'Toole L, Barthelmes D, Creuzot-Garcher C, Gillies M; Fight Retinal Blindness! Study Group. Gabrielle PH, et al. Among authors: barthelmes d. Acta Ophthalmol. 2022 Dec;100(8):e1569-e1578. doi: 10.1111/aos.15137. Epub 2022 Mar 23. Acta Ophthalmol. 2022. PMID: 35322568 Free PMC article.
Subretinal fluid may protect against macular atrophy in neovascular age-related macular degeneration: 5 years of follow-up from Fight Retinal Blindness registry.
Sánchez-Monroy J, Nguyen V, Puzo M, Calvo P, Arruabarrena C, Monaco P, Chilov M, Keegan D, Barthelmes D, Gillies M. Sánchez-Monroy J, et al. Among authors: barthelmes d. Acta Ophthalmol. 2023 Jun;101(4):457-464. doi: 10.1111/aos.15309. Epub 2022 Dec 19. Acta Ophthalmol. 2023. PMID: 36536538 Free article.
Initial observation or treatment for diabetic macular oedema with good visual acuity: two-year outcomes comparison in routine clinical practice: data from the Fight Retinal Blindness! Registry.
Gabrielle PH, Nguyen V, Bhandari S, Mehta H, Viola F, Arnold J, Fraser-Bell S, Barthelmes D, Creuzot-Garcher C, Gillies M. Gabrielle PH, et al. Among authors: barthelmes d. Acta Ophthalmol. 2022 May;100(3):285-294. doi: 10.1111/aos.14672. Epub 2020 Nov 16. Acta Ophthalmol. 2022. PMID: 33196150 Free PMC article.
Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2-year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! Registry.
Gabrielle PH, Nguyen V, Creuzot-Garcher C, Miguel L, Alforja S, Sararols L, Casaroli-Marano RP, Zarranz-Ventura J, Gillies M, Arnold J, Barthelmes D. Gabrielle PH, et al. Among authors: barthelmes d. Acta Ophthalmol. 2022 Feb;100(1):e288-e296. doi: 10.1111/aos.14893. Epub 2021 May 6. Acta Ophthalmol. 2022. PMID: 33960115 Free PMC article.
211 results